October 4, 2017
- Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin.
- No More Routine Finger Sticks for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.. See also FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration and How Abbott’s Big Win Crushed DexCom Shares.
